Weight Loss & Metabolic

5-Amino-1MQ

5-amino-1-methylquinolinium

An NAMPT inhibitor that boosts NAD+ levels and enhances energy metabolism, researched for fat loss.

Overview & Mechanism

Inhibits NNMT (nicotinamide N-methyltransferase), increasing NAD+ and restoring SIRT1 activity, which promotes fat oxidation and reduces adipocyte hypertrophy.

Research Dosage

Dose

50โ€“150 mg/day

Route

Oral or subcutaneous injection

Frequency

Once daily

Cycle

4โ€“8 weeks

Reconstitution & Storage

Reconstitution

Often supplied as a solution; for powder, reconstitute per supplier instructions with sterile or bacteriostatic water.

Storage

Per supplier; typically room temperature for powder, refrigerate reconstituted solutions.

Safety & Side Effects

Research compound. Often stacked with NAD+ protocols. Avoid in certain hormone-sensitive conditions.

Studies

NNMT inhibition reduces adiposity

Pharmacological inhibition of NNMT with 5-amino-1MQ reduced adipocyte size and body weight in mice, suggesting a therapeutic approach for obesity.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.